MeSH tree: E05.318.372
In Ontario, primary care home visits, which help older adults who are homebound or have difficulty getting to a clinic, increased during the 2010s but declined after a 2019 policy change reduced payment incentives and the ...
15 hours ago
0
0
Spinal metastasis, the spread of cancer to the spine, is a frequent complication in advanced cancer. It often causes severe pain and paralysis, significantly impacting quality of life.
Jan 26, 2026
0
0
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led by the ...
Jan 15, 2026
0
0
Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.
Jan 15, 2026
0
2
Maternal influenza and tetanus-diphtheria-acellular pertussis (Tdap) vaccinations are associated with a lower risk for influenza- and pertussis-related hospitalization or emergency department (ED) visits in infants younger ...
Jan 9, 2026
0
3
A new study has found that insufficient dietary lycopene intake is associated with a significantly higher risk of severe periodontitis among U.S. adults ages 65 to 79, with differences in risk patterns observed across race ...
Jan 8, 2026
0
39
A team of scientists and physicians at Mass General Brigham has developed a single-dose oral cholera vaccine and tested it in a phase 1 clinical trial, with results published in The Lancet Infectious Diseases.
Jan 7, 2026
0
21
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and ...
Dec 23, 2025
0
0
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, researchers from Washington ...
Dec 23, 2025
0
24
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult and pediatric patients aged 12 years and older.
Dec 22, 2025
0
0
